Greenwich LifeSciences
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell GLSI and other ETFs, options, and stocks.About GLSI
Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.
CEOSnehal S. Patel
CEOSnehal S. Patel
Employees8
Employees8
HeadquartersStafford, Texas
HeadquartersStafford, Texas
Founded2006
Founded2006
Employees8
Employees8
GLSI Key Statistics
Market cap342.41M
Market cap342.41M
Price-Earnings ratio-14.13
Price-Earnings ratio-14.13
Dividend yield—
Dividend yield—
Average volume779.60K
Average volume779.60K
High today$30.82
High today$30.82
Low today$20.68
Low today$20.68
Open price$21.19
Open price$21.19
Volume4.25M
Volume4.25M
52 Week high$30.82
52 Week high$30.82
52 Week low$7.78
52 Week low$7.78
Stock Snapshot
With a market cap of 342.41M, Greenwich LifeSciences(GLSI) trades at $23.66. The stock has a price-to-earnings ratio of -14.13.
On 2025-12-29, Greenwich LifeSciences(GLSI) stock moved within a range of $20.68 to $30.82. With shares now at $23.66, the stock is trading +14.4% above its intraday low and -23.2% below the session's peak.
Trading activity shows a volume of 4.25M, compared to an average daily volume of 779.6K.
The stock's 52-week range extends from a low of $7.78 to a high of $30.82.
The stock's 52-week range extends from a low of $7.78 to a high of $30.82.
People also own
Based on the portfolios of people who own GLSI. This list is generated using Robinhood data, and it’s not a recommendation.